Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma:A Case Report
Activity of Angiogenesis Inhibitors in Metastatic Epithelioid Hemangioendothelioma:A Case Report作者机构:Divisions of Hematology-OncologyTexas Tech University Health Science Center Divisions of Pathology Texas Tech University Health Science Center Divisions of RadiologyTexas Tech University Health Science Center
出 版 物:《Clinical oncology and cancer researeh》 (Cancer Biol. Med.)
年 卷 期:2012年第9卷第2期
页 面:133-136页
核心收录:
学科分类:1002[医学-临床医学] 100214[医学-肿瘤学] 10[医学]
主 题:hemangioendothelioma angiogenesis inhibitors nab-paclitaxel bevacizumab
摘 要:This report describes a patient with metastatic epithelioid hemangioendothelioma treated with bevacizumab and nanoparticle albumin-bound *** treatment was well tolerated and led to the stabilization of an aggressive variant of the disease. This case report is the first one that describes the activity of the combination of chemotherapy and bevacizumab in epithelioid *** describing the activity of bevacizumab and other agents(thalidomide,lenalidomide,and interferon) believed to possess anti-angiogenic activities is also reviewed.